Type 1 interferonopathies
Conditions
Interventions
None listed
Sponsors
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
Belgium, France, Germany, Italy, Portugal, Spain
Outcome results
None listed